Arthur Kuan

CIK: 0002007101

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CGON

CG Oncology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CGON
CG Oncology, Inc.
Apr 15, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
271.6K shares-
CGON
CG Oncology, Inc.
Mar 12, 2026
Exercise(M)
Direct
64.6K shares at avg. $1.72$111K
CGON
CG Oncology, Inc.
Mar 12, 2026
Tax Payment(F)
Direct
1.8K shares at avg. $60.15$111K
CGON
CG Oncology, Inc.
Mar 4, 2026
Exercise(M)
Direct
102.9K shares at avg. $1.72$177K
CGON
CG Oncology, Inc.
Mar 4, 2026
Tax Payment(F)
Direct
2.9K shares at avg. $61.61$177K
CGON
CG Oncology, Inc.
Apr 15, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
527.7K shares-
CGON
CG Oncology, Inc.
Oct 4, 2024
Award(A)
Stock Option (Right to Buy)
Direct
397.8K shares-

		Type	Shares	Price		Ownership
Apr 15, 2026	CGON CG Oncology, Inc.	Award(A) Employee Stock Option (Right to Buy)	271,600	-	-	Direct
Mar 12, 2026	CGON CG Oncology, Inc.	Exercise(M)	64,612	$1.72	$111,133	Direct
Mar 12, 2026	CGON CG Oncology, Inc.	Tax Payment(F)	1,847	$60.15	$111,097	Direct
Mar 4, 2026	CGON CG Oncology, Inc.	Exercise(M)	102,871	$1.72	$176,938	Direct
Mar 4, 2026	CGON CG Oncology, Inc.	Tax Payment(F)	2,871	$61.61	$176,882	Direct
Apr 15, 2025	CGON CG Oncology, Inc.	Award(A) Employee Stock Option (Right to Buy)	527,660	-	-	Direct
Oct 4, 2024	CGON CG Oncology, Inc.	Award(A) Stock Option (Right to Buy)	397,800	-	-	Direct

1-7 of 7 transactions

About Kuan Arthur

Kuan Arthur (SEC CIK 0002007101) files insider reports with the SEC as Chief Executive Officer of CG Oncology, Inc. (CGON).

Signal8 holds 5 ownership filings by Kuan Arthur, all Form 4s, filed between Oct 7, 2024 and Apr 16, 2026. Those filings report 7 transactions, from Oct 4, 2024 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kuan Arthur's filings is in DALLAS, TX.

Recent filings by Kuan Arthur

Apr 15, 2026: Grant or award of CGON derivative securities (Form 4, code A).
Mar 12, 2026: Option exercise of CGON shares (Form 4, code M).
Mar 12, 2026: Tax withholding of CGON shares (Form 4, code F).
Mar 4, 2026: Option exercise of CGON shares (Form 4, code M).
Mar 4, 2026: Tax withholding of CGON shares (Form 4, code F).

Other insiders filing for CG Oncology, Inc. (CGON)

Kalofonos Isabel, Chief Commercial Officer
POST LEONARD E, Director
Mulay James, Director
Liu Brian Guan-Chyun, Director
Tong Victor Edward Jr, Director
Rossi Christina, Director

How to read Form 4 transaction codes